drugset / Trial / NCT00771654
Phentermine/Gastric Band Weight Loss Study
Withdrawn
Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a prospective, randomized, double-blind controlled trial. The goal is to show whether the administration of daily oral Phentermine will augment patient weight loss and resolve obesity associated comorbidities following gastric band operation.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentermine | Small molecule | 37.5 mg | Oral |